Toronto Dominion Bank Repligen Corp Transaction History

Toronto Dominion Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $9,000 - $13,721	75 Added 1.46%	5,207 $656,000
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $312,015 - $380,783	-1,827 Reduced 26.25%	5,132 $943,000
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $357,352 - $580,145	-3,130 Reduced 31.02%	6,959 $1.25 Million
Q3 2023 Feb 14, 2024	SELL	$138.78 - $176.51 $360,411 - $458,396	-2,597 Reduced 20.47%	10,089 $1.6 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $360,411 - $458,396	-2,597 Reduced 20.47%	10,089 $1.6 Million
Q2 2023 Feb 14, 2024	BUY	$138.42 - $180.31 $792,731 - $1.03 Million	5,727 Added 82.3%	12,686 $1.79 Million
Q2 2023 Aug 10, 2023	SELL	$138.42 - $180.31 $268,673 - $349,981	-1,941 Reduced 13.27%	12,686 $1.79 Million
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $120,785 - $155,112	-783 Reduced 5.08%	14,627 $2.46 Million
Q4 2022 Feb 07, 2023	BUY	$162.42 - $220.56 $2.5 Million - $3.4 Million	15,410 New	15,410 $2.61 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.